Syneos Health, Inc. (SYNH) Announces Proposed 7M Secondary Offering

Go back to Syneos Health, Inc. (SYNH) Announces Proposed 7M Secondary Offering

Syneos Health Announces Secondary Offering of Common Stock

March 1, 2021 6:44 AM EST

MORRISVILLE, N.C., March 01, 2021 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (the Company or Syneos Health), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO (Contract Commercial Organization), today announced it commenced an underwritten secondary offering by affiliates of Thomas H. Lee Partners, L.P. and Advent International Corporation (the Selling Stockholders) of an aggregate of 7,000,000 shares of the Companys common stock (the Offering) pursuant to the Companys shelf registration statement filed with the Securities and Exchange Commission (SEC). The Selling Stockholders intend to grant the underwriter a 30-day... More